Your browser doesn't support javascript.
loading
Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial.
Peters, Solange; Stahel, Rolf A; Dafni, Urania; Ponce Aix, Santiago; Massutí, Bartomeu; Gautschi, Oliver; Coate, Linda; López Martín, Ana; van Heemst, Robbert; Berghmans, Thierry; Meldgaard, Peter; Cobo Dols, Manuel; Garde Noguera, Javier; Curioni-Fontecedro, Alessandra; Rauch, Daniel; Mark, Michael T; Cuffe, Sinead; Biesma, Bonne; van Henten, Arjen M J; Juan Vidal, Óscar; Palmero Sanchez, Ramón; Villa Guzmán, José Carlos; Collado Martin, Ricardo; Peralta, Sergio; Insa, Amelia; Summers, Yvonne; Láng, István; Horgan, Anne; Ciardiello, Fortunato; de Hosson, Sander; Pieterman, Remge; Groen, Harry J M; van den Berg, Paul M; Zielinski, Christoph C; Chittazhathu Kurian Kuruvilla, Yojena; Gasca-Ruchti, Adriana; Kassapian, Marie; Novello, Silvia; Torri, Valter; Tsourti, Zoi; Gregorc, Vanesa; Smit, Egbert F.
Afiliação
  • Peters S; University Hospital of Lausanne (CHUV), Lausanne, Switzerland. Electronic address: Solange.Peters@chuv.ch.
  • Stahel RA; University Hospital Zürich, Clinic of Oncology, Zürich, Switzerland.
  • Dafni U; Frontier Science Foundation-Hellas and National and Kapodistrian University of Athens, Athens, Greece.
  • Ponce Aix S; University Hospital 12 de Octubre, Madrid, Spain.
  • Massutí B; Alicante University Hospital, Alicante, Spain.
  • Gautschi O; Swiss Group for Clinical Cancer Research and Cantonal Hospital Lucerne, Switzerland.
  • Coate L; Cancer Trials Ireland and Mid-Western Regional Hospital, Limerick, Ireland.
  • López Martín A; University Hospital Severo Ochoa, Madrid, Spain.
  • van Heemst R; Deventer Hospital, Deventer, The Netherlands.
  • Berghmans T; Institute Jules Bordet, Brussels, Belgium.
  • Meldgaard P; Aarhus University Hospital, Aarhus, Denmark.
  • Cobo Dols M; University Hospital Virgen de la Victoria, Malaga, Spain.
  • Garde Noguera J; Hospital Arnau Vilanova, Valencia, Spain.
  • Curioni-Fontecedro A; University Hospital Zürich, Clinic of Oncology, Zürich, Switzerland.
  • Rauch D; Cantonal Hospital, Thun, Switzerland.
  • Mark MT; Cantonal Hospital, Chur, Switzerland.
  • Cuffe S; Cancer Trials Ireland and St. James's Hospital, Dublin, Ireland.
  • Biesma B; Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
  • van Henten AMJ; Maxima Medical Centre, Eindhoven, The Netherlands.
  • Juan Vidal Ó; Hospital La Fe, Valencia, Spain.
  • Palmero Sanchez R; Hospital Duran i Reynalds, Barcelona, Spain.
  • Villa Guzmán JC; General University Hospital, Ciudad Real, Spain.
  • Collado Martin R; Hospital San Pedro de Alcantara, Spain.
  • Peralta S; Hospital Sant Joan de Reus, Spain.
  • Insa A; University Hospital, Valencia, Spain.
  • Summers Y; Christie Hospital Manchester, United Kingdom.
  • Láng I; National Institute of Oncology, Budapest, Hungary.
  • Horgan A; Cancer Trials Ireland and University Hospital Waterford, Ireland.
  • Ciardiello F; Second University of Naples, Naples, Italy.
  • de Hosson S; Wilhelmina Hospital, Assen, The Netherlands.
  • Pieterman R; Ommelander Hospital Group, Winschoten, The Netherlands.
  • Groen HJM; University Medical Center Groningen, The Netherlands.
  • van den Berg PM; Maasstad Hospital, Rotterdam, The Netherlands.
  • Zielinski CC; Central European Cooperative Oncology Group and Comprehensive Cancer Center of the Medical University, Vienna, Austria.
  • Chittazhathu Kurian Kuruvilla Y; European Thoracic Oncology Platform Coordinating Office, Bern, Switzerland.
  • Gasca-Ruchti A; European Thoracic Oncology Platform Coordinating Office, Bern, Switzerland.
  • Kassapian M; Frontier Science Foundation-Hellas, Athens, Greece.
  • Novello S; University of Turin, Department of Clinical and Biological Sciences, Turin, Italy.
  • Torri V; Mario Negri Institute for Pharmacological Research, Milan, Italy.
  • Tsourti Z; Frontier Science Foundation-Hellas, Athens, Greece.
  • Gregorc V; IRCCS Scientific Institute Ospedale San Raffaele, Milan, Italy.
  • Smit EF; Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
J Thorac Oncol ; 12(4): 752-762, 2017 04.
Article em En | MEDLINE | ID: mdl-28017787
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: J Thorac Oncol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: J Thorac Oncol Ano de publicação: 2017 Tipo de documento: Article